Biosimulation Industry Forecast, 2029: Analysis of Case Studies, Market Dynamics, Regional Growth Trends, Regulatory Landscape, Value Chain, and Competitive Intelligence [Yahoo! Finance]
Simulations Plus, Inc. (SLP)
Last simulations plus, inc. earnings: 4/9 04:35 pm
Check Earnings Report
US:NASDAQ Investor Relations:
simulations-plus.com/software/overview
Company Research
Source: Yahoo! Finance
The biosimulation market is projected to reach USD 9.18 billion by 2029 from USD 4.24 billion in 2024, rising at a CAGR of 16.7% from 2024 to 2029. The increasing need for cost and time reduction in the drug development process has been one of the major drivers in the adoption of biosimulation tools. But there are some restraining factors in the market; the cost of biosimulation technologies is discouragingly high and thus, prohibitive to small companies and the academic community. Drug Discovery held the largest market share in the biosimulation market in 2023, by application The drug discovery segment held the largest market share since it plays a vital role in accelerating and enriching early stages of pharmaceutical research. The tool created by biosimulation makes it possible for the researchers to simulate drug behavior at the molecular level, predict biological target interaction, even identify potential drug candidates before they reach the costly phases of preclinical
Show less
Read more
Impact Snapshot
Event Time:
SLP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SLP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SLP alerts
High impacting Simulations Plus, Inc. news events
Weekly update
A roundup of the hottest topics
SLP
News
- Simulations Plus Announces First Quarter Fiscal Year 2025 Earnings and Conference Call DateBusiness Wire
- Simulations Plus, Inc.'s (NASDAQ:SLP) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock? [Yahoo! Finance]Yahoo! Finance
- Simulations Plus (SLP) Stock Jumps 8.9%: Will It Continue to Soar? [Yahoo! Finance]Yahoo! Finance
- Biosimulation Market to Hit USD 9.18 Billion by 2029 with 16.7% CAGR | MarketsandMarkets™. [Yahoo! Finance]Yahoo! Finance
- Simulations Plus to Participate in the BTIG Digital Health ForumBusiness Wire
SLP
Earnings
- 10/23/24 - Beat
SLP
Sec Filings
- 12/3/24 - Form 4
- 12/3/24 - Form 4
- 12/2/24 - Form 144
- SLP's page on the SEC website